Process of purifying tadalafil
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TEVA PHARMA IND LTD
- Publication Date
- 2008-02-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
[0001] related application
[0002] This application claims the benefit of U.S. Provisional Application 60 / 656,664, filed February 25, 2005; U.S. Provisional Application 60 / 683,058, filed May 19, 2005; U.S. Provisional Application 60 / 736,807, filed November 14, 2005; and Priority to US Provisional Application 60 / 737,080, filed November 15, 2005, and US Provisional Application 60 / 677,514, filed May 3, 2005. The contents of these applications are hereby incorporated by reference. technical field
[0003] The present invention relates to a method of purifying tadalafil by crystallization. Background technique
[0004] Tadalafil, (6R-trans)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2- Methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, which has the structural formula shown below, is a white crystalline powder . (CAS#171596-29-5). Tadalafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase PDE5. Inhibiting...